BRAND NAME- Fragment analyzer, computer, monitor, controller, analysis software, capillary array, Installation/familiarization

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2228671 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) FAC 2024-05 May 22, 2024
 
The North American Industry Classification System (NAICS) code for this procurement is 334516, Analytical Laboratory Instrument Manufacturing, with a size standard of 1000 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.

MANUFACTURER – AGILENT LIFE SCIENCES 
1)    CAT # M5310AA – Qty: 1 Includes 5200 Fragment analyzer, computer, monitor, controller, analysis software, capillary array, Installation/familiarization
2)    CAT # DNF-FSEW-OQ QTY: 1  Fragment Analyzer Verification Kit 
3)    Freight Charge (FOB SESTINATION)
Shipping location: 
9 West Watkins Mill Road
Gaithersburg, MD 20878

Brand name justification: The measurement of purity and size are two critical quality attributes (mandatory quality measure) of any investigational new drug approved by the US Food and Drug Administration (US-FDA). The Vaccine Production Program (VPP) is currently working on the development of mRNA vaccine which purity and size need to be accurately measured. Fragment analyzer 5200 (FA5200) from Agilent was designed to provide the measurement with quality for size and percent purity analysis of nuclear acid (DNA/RNA) samples. FA5200 currently is widely applied in many mainstream pharmaceutical companied including Pfizer, Moderna and GSK for the mRNA vaccine R&D.  Purchase of FA5200 is required for VPP program growth. The new instrument will support current organization mission needs for mRNA vaccine development’s quality controls.
 
Place of Performance: NIH, NIAID, 9 West Watkins Mill Road, Gaithersburg, MD 20878

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.  The award will be based on the following: technical capability to meet the requirements and price.

The following FAR provisions apply to this acquisition: 
FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Feb 2024)

FAR 52.204-7 System for Award Management (OCT 2018)

(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)

52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26

The following FAR contract clauses apply to this acquisition:

FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2022)

FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (MAY 2024)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)

FAR 52.204-13 System for Award Management Maintenance (OCT 2018)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)

FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address:  http://farsite.hill.af.mil/vffara.htm

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Submission shall be received not later than August 17, 2024 @ 4:00 PM EST

Offers may be e-mailed to Diana Rohlman (E-Mail/ diana.rohlman@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIAID-24-2228671). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) 

All responsible sources may submit an offer that will be considered by this Agency.  
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Diana Rohlman at diana.rohlman@nih.gov.